Full name
GLENMARK PHARMACEUTICALS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
GLENMARK PHARMACEUTICALS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. JÓZEFA PIUSA DZIEKOŃSKIEGO 3, 00-728 WARSZAWA
TAX ID5272576515
Rate company:
GLENMARK PHARMACEUTICALS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5272576515
KRS0000308877
Share capital5,000,000.00 zł
address
UL. JÓZEFA PIUSA DZIEKOŃSKIEGO 3, 00-728 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5272576515
REGON
141450550
KRS
0000308877
Legal form
limited liability company
Register Address
UL. JÓZEFA PIUSA DZIEKOŃSKIEGO 3, 00-728 WARSZAWA
Date of registration in KRS
2008-07-02
Date of commencement of economic activity
2008-07-02
Act signature
RDF/676043/24/514
Pkd codes
46.46.Z - Wholesale of pharmaceutical goods
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.45.Z - Wholesale of perfume and cosmetics
46.75.Z - Wholesale of chemical products
46.76.Z - Wholesale of other intermediate products
52.10.B - Warehousing and storage of other goods
64.20.Z - Activities of holding companies
73.1 - Advertising
82.99.Z - Other business support service activities not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL92 1600 1462 1744 1083 6000 0004 
PL76 1600 1462 1744 1083 6000 0001 PL65 1600 1462 1744 1083 6000 0005 PL49 1600 1462 1744 1083 6000 0002 PL22 1600 1462 1744 1083 6000 0003 
PL11 1030 1508 0000 0008 0480 1014 Show more bank accounts from VAT list (3)
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2023 | 2024 | ||
|---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss)  | 0,2 | 2,8 | 1067 |
EBITDA | 2 | 3,2 | 65,1 |
Short time liabilities | 36,2 | 36,1 | -0,3 |
Equity capital | 3,6 | 5,7 | 60,1 |
Operating profit (EBIT) | 1,8 | 2,8 | 58,9 |
Assets | 64,2 | 67,3 | 4,9 |
Net profit (loss) | 0,1 | 2,1 | 1608,5 |
Cash | 9 | 5,5 | -39,1 |
Liabilities and provisions for liabilities | 60,6 | 61,6 | 1,7 |
Net income from sale | 88,7 | 99,2 | 11,9 |
Working assets | 59 | 62,6 | 6,1 |
Depreciation | 0,2 | 0,4 | 128,4 |
% | % | p.p. | |
Profitability of capital | 3,5 | 37,5 | 34 |
Equity capital to total assets | 5,5 | 8,5 | 3 |
Gross profit margin | 0,3 | 2,8 | 2,5 |
EBITDA Margin | 2,2 | 3,3 | 1,1 |
Days | Days | Days | |
Short term commitment turnover cycle | 149 | 133 | -16 |
Financial statements
01-04-2023 - 31-03-2024
Annual financial report
Download xml01-04-2023 - 31-03-2024
Annual financial report
Download pdf01-04-2023 - 31-03-2024
Activity report
Download pdf01-04-2023 - 31-03-2024
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-04-2023 - 31-03-2024
Resolution on profit distribution or loss coverage
Download pdf01-04-2023 - 31-03-2024
Resolution or decision approving the annual financial statements
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Sis-Med sp. z o.o.
Łódź
BEATA BOGDZIEWICZ AB-MED
Tychy
Miodla Poland sp. z o.o.
Pszczyna
CYTOGEN-POLSKA
ŁÓDŹ
"INSANIX MEDICAL" sp. z o.o.
Kielce
Bardomed sp. z o.o.
Kraków
Gama Sp. z o.o.
Ruda Śląska
Sklep Zielarsko-Medyczny Zielmed24
Włoszczowa